ARCHIVES

Celgene Begins Two Studies With Hoffmann-La Roche.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Lines Drawn Over HHS Appropriations.

October 5, 2007

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

March 11, 1977

White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis

July 22, 1977

Obey Raps Reagan Administration For Blocking Report On Formaldehyde Danger

March 27, 1981

Environmental Carcinogenesis Gets 17% Of NCI Budget

February 20, 1976

Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy

November 25, 2011